EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives

Norma Carolina Hernandez-Bautista, Claudia Altamirano-Torres, Jose Manuel Vazquez-Guillen, Reyes S Tamez-Guerra, Cristina Rodríguez-Padilla, Diana Resendez-Perez

Frontiers in Oncology · 15.06.2026 · 16

DOI: 10.3389/fonc.2026.1807003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 15.06.2026. Verfasst von Norma Carolina Hernandez-Bautista und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, San Nicolás de los Garza, Nuevo Leó…. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulated genomic and transcriptomic evidence in head and neck squamous cell carcinoma (HNSCC) has revealed widespread molecular alterations associated with tumor initiation, progression, and therapeutic resistance. Among these, deregulation of HOX genes has emerged as a prominent feature of cancer biology. HOX genes encode a highly-conserved family of transcription factors that regulate essential cellular processes, including proliferation, differentiation, migration, and survival, all of which are directly relevant to tumor development. However, their clinical exploitation as reliable biomarkers or therapeutic targets remains limited, underlining the need to identify functionally relevant molecular drivers. This mini-review provides an updated overview of HOX gene dysregulation in HNSCC, highlighting their context-dependent roles as oncogenes or tumor suppressors. We synthesize current evidence on the molecular mechanisms and regulatory networks governing HOX activity and evaluate their emerging clinical relevance as biomarkers and therapeutic targets. Finally, we identify critical knowledge gaps and propose future directions to advance HOX -focused translational research in HNSCC.

Schlagwörter

Stichwörter der Autor:innen

HOX geneshead and neck cancerhomeoboxhomeotic genessquamous cell carcinoma

Autor:innen und Institutionen

  • Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, San Nicolás de los Garza, Nuevo León, Mexico.
  • Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Laboratorio de Inmunología y Virología, San Nicolás de los Garza, Nuevo León, Mexico.

Zitieren

APA

Hernandez-Bautista, N. C., Altamirano-Torres, C., Vazquez-Guillen, J. M., Tamez-Guerra, R. S., Rodríguez-Padilla, C., & Resendez-Perez, D. (2026). HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1807003

Vancouver

Hernandez-Bautista NC, Altamirano-Torres C, Vazquez-Guillen JM, Tamez-Guerra RS, Rodríguez-Padilla C, Resendez-Perez D. HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1807003

BibTeX
@article{HernandezBautista2026,
  author = {Hernandez-Bautista, Norma Carolina and Altamirano-Torres, Claudia and Vazquez-Guillen, Jose Manuel and Tamez-Guerra, Reyes S and Rodríguez-Padilla, Cristina and Resendez-Perez, Diana},
  title = {HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1807003}
}
Kostenlos starten →